药物诱导的急性肝炎与西相关:一个病例报告
Carolina Guimarães1, Rui Ribeiro2, Helena Hipólito Reis1
1Internal Medicine, Unidade Local de Saúde São João, Porto, PRT.
Cureus
|January 1, 2026
概括
药物诱导性肝损伤 (DILI) 由于沃尔托克塞是罕见但严重的. 一名患者在服用伏西丁后经历了肝损伤,在戒断后出现改善,在重新暴露后恶化,突出显示了与抗抑郁药物相关的肝毒性风险.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- 药物诱导性肝损伤 (DILI) 是抗抑郁药物的罕见副作用.
- 伏尔托克塞丁通常用于严重抑郁症,具有良好的安全性.
- 与西相关的肝毒性很少被报告.
研究的目的:
- 报告与西相关的急性肝炎病例与胆固醇学特征.
- 为了调查子素诱导的肝损伤的可能性.
- 为了突出DILI与色胺抗抑郁药的风险.
主要方法:
- 一个59岁的女性患者的病例报告.
- 评估包括排除病毒性,自身免疫性和代谢性肝病的原因.
- 为了评估因果关系,进行了药物停用和再试用.
- 随后的暴露于文拉法辛也被注意到.
主要成果:
- 患者在长期使用西后出现了具有胆固醇特征的急性肝炎.
- 伏西丁戒药后肝功能恢复正常,但在重新戒药时恶化.
- 拉法辛暴露后发生了随后的肝衰竭发作.
- 在停止抗抑郁药物和N-乙半氨酸治疗后,恢复得到.
结论:
- 伏尔托克塞丁可以引起DILI,呈现为具有胆固醇特征的急性肝炎.
- 在Rechallenge的研究中,证实了沃尔提奥塞丁诱导的肝毒性.
- 该案例表明SSRI中可能存在与类相关的肝毒性.
- 临床医生应考虑在接受子或其他血清抗抑郁药的患者中使用DILI.
相关概念视频
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
185
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
185
Antiepileptic Drugs: Potassium Channel Activators
590
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
590
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
234
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
234
Therapeutic Drug Monitoring: Affecting Factors
170
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
170
Hepatic Drug Excretion: Influencing Factors
502
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
502
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K


